CRIS Current Research Information System

VAIRA, BERARDINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.121
NA - Nord America 8.660
AS - Asia 3.538
AF - Africa 228
SA - Sud America 114
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 10
Totale 23.690
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.631
IT - Italia 6.046
GB - Regno Unito 1.504
CN - Cina 1.349
SG - Singapore 1.191
DE - Germania 765
SE - Svezia 650
VN - Vietnam 476
UA - Ucraina 424
RU - Federazione Russa 379
IN - India 308
NL - Olanda 288
FR - Francia 249
IE - Irlanda 239
ZA - Sudafrica 123
BG - Bulgaria 117
EE - Estonia 112
FI - Finlandia 103
BR - Brasile 94
CH - Svizzera 88
JO - Giordania 87
SC - Seychelles 35
BE - Belgio 31
AT - Austria 30
TG - Togo 27
CI - Costa d'Avorio 25
CA - Canada 23
JP - Giappone 19
ES - Italia 18
ID - Indonesia 18
AL - Albania 16
EU - Europa 16
GR - Grecia 16
HK - Hong Kong 16
TR - Turchia 14
LB - Libano 12
RO - Romania 11
BD - Bangladesh 8
LY - Libia 8
AU - Australia 7
IR - Iran 7
PL - Polonia 7
LT - Lituania 6
PE - Perù 6
CZ - Repubblica Ceca 5
VE - Venezuela 5
CL - Cile 4
EG - Egitto 4
HR - Croazia 4
IL - Israele 4
MX - Messico 4
PT - Portogallo 4
UZ - Uzbekistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
IQ - Iraq 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
TW - Taiwan 3
BO - Bolivia 2
DK - Danimarca 2
KR - Corea 2
KZ - Kazakistan 2
MA - Marocco 2
NO - Norvegia 2
PK - Pakistan 2
AR - Argentina 1
BA - Bosnia-Erzegovina 1
CO - Colombia 1
CR - Costa Rica 1
CV - Capo Verde 1
EC - Ecuador 1
GL - Groenlandia 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
LU - Lussemburgo 1
MM - Myanmar 1
MT - Malta 1
MY - Malesia 1
OM - Oman 1
PH - Filippine 1
SI - Slovenia 1
TL - Timor Orientale 1
Totale 23.690
Salva come PNG Salva come JPEG
Città #
Southend 1.352
Singapore 1.038
Santa Clara 870
Fairfield 814
Chandler 673
Milan 567
Ashburn 530
Boardman 526
Rome 430
Woodbridge 416
Wilmington 398
Seattle 376
Princeton 367
Houston 348
Bologna 305
Jacksonville 289
Cambridge 283
Ann Arbor 249
Dong Ket 246
Dublin 239
Naples 200
Padova 179
Nanjing 154
Westminster 149
Turin 131
Sofia 117
Berlin 113
Bari 91
Florence 90
Helsinki 90
Amman 87
New York 79
Jinan 78
Saint Petersburg 69
Beijing 65
Shenyang 65
Palermo 64
Catania 61
Tappahannock 60
San Diego 58
Mülheim 57
Nanchang 55
Verona 55
Frattamaggiore 50
Guangzhou 50
Shanghai 50
Brescia 45
Changsha 42
Tianjin 42
Genoa 41
Redmond 41
Falkenstein 37
Hebei 36
Zhengzhou 36
Yubileyny 35
Dearborn 33
Mahé 33
Des Moines 32
Trieste 30
Boydton 28
Brussels 28
Hangzhou 28
Reggio Emilia 28
Lomé 27
Los Angeles 27
Abidjan 25
Medford 24
Livorno 23
Parma 23
Modena 22
Mountain View 22
Venice 22
Bern 20
Pescara 20
Imola 18
Norwalk 18
Reggio Calabria 18
Shenzhen 18
Wuhan 18
Cagliari 17
Hyderabad 17
Jakarta 17
Redwood City 17
Taiyuan 17
Tokyo 17
Bergamo 16
Forlì 16
Haikou 16
Kunming 16
Lucca 16
Nuremberg 16
San Venanzo 16
Treviso 16
Chengdu 15
Fuzhou 15
Shijiazhuang 15
Jiaxing 14
London 14
Napoli 14
Perugia 14
Totale 13.904
Salva come PNG Salva come JPEG
Nome #
Helicobacter pylori. Benedetto il giorno che ti ho incontrato 4.223
Nuovi orientamenti terapeutici per l’infezione da Helicobacter pylori: la terapia sequenziale. 833
Ruolo dei batteri componenti la flora intestinale nell’eziopatogenesi della colite ulcerosa e del cancro del colon: i Fusobatteri e il Bacteroides fragili enterotossico prendono la scena. 446
Sequenze genomiche dei batteri filamentosi segmentati negli animali da laboratorio. Implicazioni per la ricerca sull’uomo 286
Change of point mutations in helicobacter pylori rRNA associated with clarithromycin resistance in Italy 192
Accuracy of a new ultra fast rapid urease test to diagnose Helicobacter pylori infection in 1000 consecutive patients 180
Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection: a randomised controlled trial 166
A new 24 h ELISA culture based method for Helicobacter pylori chemosusceptibility 165
H. pylori antibiotic resistance and 13C urea breath test values. 161
Effects of Helicobacter pylori eradication on early-stage gastric mucosa associated lymphoid tissue lymphoma. 150
13C-urea breath test values and Helicobacter pylori eradication 150
A validation study of the Italian Short-Form Leeds Dyspepsia Questionnaire 149
Effetti avversi gastrointestinali: farmaci anti-infiammatori non steroidei ed Helicobacter pylori 145
A 10 days levofloxacin base triple therapy in patients who failed two eradication courses 145
Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016 145
Levofloxacin-based triple therapy for Helicobacter pylori retreatment: role of bacterial resistance. 139
A Rapid Immunochromatographic Assay for Helicobacter pylori in Stool before and after Treatment 138
Antibiotic resistance and therapy for H. pylori infection in immigrant patients managed in Italy 138
Cross-sectional study: CagA-positive helicobacter pylori infection, acute coronary artery disease and systemic levels of B-type natriuretic peptide 137
Effect of Proton Pump Inhibitors and Antacid Therapy on 13C-Urea Breath Tests and Stool Test for Helicobacter pylori Infection 137
A human domain antibody and Lewisb–glyconjugate that inhibit binding of Helicobacter pylori to Lewisb receptor and inhibit bacterial adhesion to human gastric epithelium 132
A comparison among three rapid urease tests to diagnose Helicobacter pylori infection in 375 consecutive dyspeptic 131
Test rapido per la determinazione della chemiosensibilità dell'Helicobacter pylori 130
Antimicrobial Efficacy of Five Probiotic Strains Against Helicobacter Pylori 130
A novel stool PCR test for helicobacter pylori may predict clarithromycin resistance and eradication of infection at a high rate 129
Antibiotic resistance and therapy outcome in H. pylori eradication failure patients. 127
The Effects of Two Novel Copper-Based Formulations on Helicobacter pylori 124
Accuracy of urea breath tests tablets after 10 minutes compared to standard 30 minutes to diagnose and monitoring Helicobacter pylori infection: a randomised controlled trial 123
Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease 122
Gastroesophageal Reflux Disease and Barrett’s Esophagus 122
Phenotypic and genotype H. pylori Clarithromycin resistance and therapeutic outcomes: benefit and limits. 121
Culture-based Selection Therapy for Patients Who Did Not Respond to Previous Treatment for Helicobacter pylori Infection 121
Tablet and oral liquid L-thyroxine formulation in the treatment of naive hypothyroid patients with Helicobacter pylori infection 121
How useful is the rapid urease test for evaluating the success of Helicobacter pylori eradication therapy? 120
A combination of faecal tests for the detection of colon cancer: a new strategy for appropriate selection of referrals to colonoscopy ? A prospective multicenter italian study. 119
In vivo dissolution of levothyroxine soft gel capsules 119
Are Helicobacter Species and Enterotoxigenic Bacteroides fragilis Involved in Inflammatory Bowel Disease? 118
E-test for Metronidazole Susceptibility Q1 in H pylori: Use of the Wrong Standard May Have Led to the Wrong Conclusion: Reply 117
Cameron lesions: A still overlooked diagnosis. Case report and systematic review of literature 117
Treatment of Helciobacter pylori infection 2014 114
An Atlas of Investigation and Management: HELICOBACTER PYLORI 114
Helicobacter pylori eradication: Are we really all equal? A controlled study in native and immigrant population 114
Epidemiologia dell’Infezione da Helicobacter pylori e Cancro gastrico non cardiale. Insegnamenti per il futuro. 113
CagA and VacA are immunoblot markers of past Helicobacter pylori infection in atrophic body gastritis 111
How to proceed in H pylori-positive chronic gastritis refractory to first and second line eradication therapy. 110
Primary antibiotic resistance in Helicobacter pylori strains isolated in Northern and Central Italy. 110
Diagnosis of Helicobacter pylori: invasive and non- invasive tests 109
Diagnosi dell'infezione da Helicobacter pylori 108
Nuove terapie per curare l’infezione da Helicobacter pylori 107
Quantification of Serum Levels of Pepsinogens and Gastrin to Assess Eradication of Helicobacter Pylori 107
Diagnosi dell’infezione da Helicobacter pylori 106
La terapia gastroprotettiva nel paziente cardiopatico: un problema sempre attuale. 105
Changing prevalence of Helicobacter pylori infection and peptic ulcer among dyspeptic patients 105
Diagnosi non invasiva e terapia per Helicobacter Pylori 105
Minimal inhibitory concentration (MIC) values and different point mutations in the 23S rRNA gene for Clarithromycin resistance in Helicobacter pylori. 104
Management of helicobacter pylori infection-the Maastricht V/Florence consensus report 104
Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication 104
Helicobacter pylori: current status and future prospects 103
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and Meta-analysis of randomized controlled trials in adults and children. 103
Glaucoma and Helicobacter pylori: Eyes wide shut? 103
Helicobacter pylori and functional dyspepsia: an unsolved issue? 102
Considerable use of furazolidone in Iran. 102
Sequential therapy for H. pylori: an “aberrant” therapy ready for general use. 101
Global eradication rates for helicobacter pylori infection: systematic review and meta-analysis of sequantial therapy 101
Efficacy of a New Nutraceutical Formulation in Patients with Symptomatic Uncomplicated Diverticular Disease (SUDD): a Prospective Observational Study 101
Efficacy of 5-ASA in the treatment of colonic diverticular disease. 100
Peptic ulcer and Helicobacter pylori. 100
The prevalence of celiac disease in children with type 1 diabetes mellitus increased in the mid nineties: an 18-yr longitudinal study based on anti-endomysial antibodies 100
Colonization by Helicobacter pylori of leprosy patients in Spain: immunomodulation to low molecular weight antigens of H pylori 99
Serological markers for gastric atrophy in asymptomatic subjects infected with Helicobacter pylori. 98
Stool test for Helicobacter pylori 97
high Prevalence of Primary Antibiotic Resistance in Helicobacter pylori Isolates in Italy 97
Treatment of Helicobacter pylori infection 96
Valutazione dell’accuratezza del nuovo urea breath test a lettura rapida nell’infezione da Helicobacter pylori. 95
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and Meta-analysis of randomized controlled trials in adults and children 95
A Systematic Review on Drugs Absorption Modifications after Eradication in Helicobacter pylori Positive Patients undergoing Replacement Therapy 95
Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains 95
Treatment of Helicobacter Pylori in Latin America 94
Sequential therapy for H pylori eradication: is Levofloxacin better? 94
Therapy for H. pylori: Current concepts 94
Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori 94
High Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study 93
Twice daily standard dose of omeprazole achieves the necessary level of acid inhibition for Helicobacter pylori eradication. A randomised controlled trial using standard and double doses of omeprazole within a triple therapy 92
The sequential therapy regimen for Helicobacter pylori eradication. 92
Attuali criteri di terapia dell’infezione da Helicobacter pylori. New treatment of Helicobacter pylori infection 92
Response to Dr Osato and Graham 91
Growth and adult height in atypical coeliac patients, with or without growth hormone deficiency. 91
Failure of first line eradication treatment significantly increases prevalence of anti-microbial resistant helicobacter pylori clinical isolates. 91
Power of screening tests for colorectal cancer enhanced by high levels of M2-PK in addition to FOBT 91
Proton pump inhibitors and antiplatelet drugs in clinical cardiology. 90
Standard triple and sequential therapies for Helicobacter pylori eradication: An update 90
Expression of COX-2, mPGE synthase 1, MDR-1 (P-GP) and BCL-XL: a molecular pathway of H pylori related-gastric carcinogenesis. 90
How often do you fail to take all of your medication? 90
Attuali criteri di terapia dell'infezione da Helicobacter pylori 89
Rifabutin Triple Therapy is Effective in Patients With Multidrug-resistant Strains of Helicobacter pylori 89
The A2143G point mutation of Clarithromycin resistance affects H. pylori eradication 88
How long will it take to reduce gastric cancer incidence by eradicating Helicobacter pylori infection? 88
Is Double-Dose Esomeprazole With Bismuth Really Safe? 88
Infezione da Helicobacter pylori e nuovi orientamenti terapeutici: la terapia sequenziale 87
Probiotici ricombinanti e loro potenziale sulla salute umana 87
Totale 16.586
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.898
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.898
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.083 0 0 0 0 0 0 0 0 430 247 111 295
2020/20211.957 445 163 83 92 36 92 43 120 142 117 99 525
2021/20222.935 308 81 181 295 292 137 60 219 91 92 706 473
2022/20233.143 317 376 185 343 170 237 129 184 588 143 316 155
2023/20243.414 486 337 191 293 188 295 170 130 145 361 431 387
2024/20257.656 558 1.070 609 676 1.988 695 964 631 465 0 0 0
Totale 24.366